| Literature DB >> 23429272 |
Ching-Chyuan Su1, Bing-Sang Wong, Chuen Chin, Yu-Jen Wu, Jui-Hsin Su.
Abstract
Chemical examination of the Taiwanese soft coral Sinularia flexibilis led to the isolation of five cembrane-based diterpenoids 1-5, including two new metabolites, 11-acetylsinuflexolide (1) and 11-acetyldihydrosinuflexolide (2). The structures of the new metabolites were determined based on extensive spectroscopic analysis, particularly mass spectrometry and 2D NMR (1H-1H COSY, HMQC, HMBC, and NOESY) spectroscopy. Metabolites 1, 3 and 4 exhibited moderate to weak cytotoxicity to human tumor cell lines, HeLa, HEp-2, MCF-7 and MDA-MB-231.Entities:
Year: 2013 PMID: 23429272 PMCID: PMC3588100 DOI: 10.3390/ijms14024317
Source DB: PubMed Journal: Int J Mol Sci ISSN: 1422-0067 Impact factor: 5.923
Figure 1The soft coral Sinularia flexibilis.
Figure 2Structures of metabolites 1–5.
1H and 13C NMR data for 1 and 2.
| C/H | 1 | 2 | ||
|---|---|---|---|---|
|
|
| |||
| δH ( | δC (mult.) | δH ( | δC (mult.) | |
| 1 | 2.75 m | 36.7 (CH) | 1.71 m | 38.4 (CH) |
| 2 | 2.25 m; 1.57 m | 29.3 (CH2) | 2.24 m; 1.44 m | 29.8 (CH2) |
| 3 | 4.05 d (11.5) | 84.5 (CH) | 4.05 d (11.5, 2.5) | 85.0 (CH) |
| 4 | 73.7 (C) | 73.7 (C) | ||
| 5 | 1.83 m; 1.77 m | 37.8 (CH2) | 1.77 m | 37.5 (CH2) |
| 6 | 2.28 m; 2.02 m | 22.1 (CH2) | 2.28 m; 1.98 m | 22.1 (CH2) |
| 7 | 5.26 dd (7.5, 7.5) | 127.2 (CH) | 5.23 dd (7.0, 7.0) | 127.2 (CH) |
| 8 | 135.1 (C) | 135.0 (C) | ||
| 9 | 2.31 m; 1.93 m | 35.3 (CH2) | 2.27 m; 1.92 m | 35.1 (CH2) |
| 10 | 1.92 m; 1.72 m | 27.9 (CH2) | 1.90 m; 1.72 m | 28.1 (CH2) |
| 11 | 4.79 dd (6.5, 2.5) | 77.5 (CH) | 4.80 dd (7.0, 2.0) | 77.2 (CH) |
| 12 | 74.8 (C) | 74.8 (C) | ||
| 13 | 1.74 m; 1.53 m | 35.2 (CH2) | 1.68 m; 1.48 m | 36.1 (CH2) |
| 14 | 1.92 m; 1.36 m | 28.6 (CH2) | 1.68 m; 1.12 m | 28.7 (CH2) |
| 15 | 140.4 (C) | 2.09 m | 43.5 (CH) | |
| 16 | 166.6 (C) | 174.8 (C) | ||
| 17 | 6.43 d (2.0); 5.63 d (2.0) | 125.5 (CH2) | 1.35 d (7.0) | 15.3 (CH3) |
| 18 | 1.38 s | 25.5 (CH3) | 1.39 s | 25.6 (CH3) |
| 19 | 1.62 s | 16.1 (CH3) | 1.62 s | 16.4 (CH3) |
| 20 | 1.19 s | 25.4 (CH3) | 1.17 s | 25.4 (CH3) |
| OAC | 170.6 (C) | 170.6 (C) | ||
| 2.11 s | 21.1 (CH3) | 2.11 s | 21.1 (CH3) | |
500 MHz in CDCl3;
125 MHz in CDCl3.
Figure 3The structures of metabolites 1 and 2 and selected 1H-1H COSY (−) and HMBC (→) correlations.
Cytotoxicity (IC50 μg/mL) of compounds 1–5.
| Compound | Cell Lines | |||
|---|---|---|---|---|
|
| ||||
| HeLa | HEp-2 | MCF-7 | MDA-MB-231 | |
| 9.5 | 11.3 | 17.8 | 15.7 | |
| NA | NA | NA | NA | |
| 8.6 | 8.2 | 16.0 | 11.3 | |
| NA | 12.6 | 17.5 | 13.5 | |
| NA | NA | NA | NA | |
| 0.05 | 0.1 | 0.07 | 0.5 | |
Clinical anticancer drug as positive control;
NA, not active at 20 μg/mL.